| DB ID | MyCo_6395 |
| Title | Gliotoxin effects on fungal growth: mechanisms and exploitation |
| Year | 2012 |
| PMID | 22405895 |
| Fungal Diseases involved | Aspergillus fumigatus infection |
| Disease | Aspergillosis (Aspergillus Infection) |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | None |
| Site of Infection | Unspecified |
| Opportunistic invasive | None |
| Sample type | Extracted Conidia |
| Sample source | Extracted Conidia |
| Host Group | NA |
| Host Common name | NA |
| Host Scientific name | NA |
| Biomarker Name | Gliotoxin (14 lg/ml) |
| Biomarker Full Name | Gliotoxin (14 lg/ml) |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Ireland |
| Cohort | None |
| Cohort No. | None |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| Fold Change | 2.5–3.5 fold |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Sub Technique | LC-MS |
| Technique | Mass Spectrometry |
| Analysis Method | Reversed phase HPLC Analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Reversed phase HPLC Analysis |
| Up Regulation Down Regulation | Increase |
| Sequence Data | CADRE I.D: GliT (AFUA_6G09740) |
